InvestorsHub Logo
icon url

sukus

06/27/20 2:15 PM

#292138 RE: beartrap12 #292123

Thank you. Excellent info. nGBM and rGBM? Very nice.
icon url

sentiment_stocks

06/28/20 3:50 AM

#292179 RE: beartrap12 #292123

I know you mentioned the compassionate care patients... so in addition to the information arm (55), I suspect there’s around 90 in the EAP trial. I’m not sure if they could have taken any non approved treatments along with DCVax-L. The following clause sorta of indicates that they could, but I’m thinking that it would have been at the investigators discretion?

This trial would be for the rapid/pseudo-progression patients.

There are no therapeutic restrictions, but guidelines for drug administration are recommended as per the 020221 protocol.


https://clinicaltrials.gov/ct2/show/NCT02146066?cond=DCVax-l&draw=2&rank=2